These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1645052)

  • 1. Embolism and atrial fibrillation. A longitudinal follow-up.
    Yipintsoi T; Jirathamopas W; Suntiparpluacha C; Jintapakorn W; Akaravinake A; Kunjara-Na-Ayudhya R
    J Med Assoc Thai; 1992 Feb; 75(2):73-8. PubMed ID: 1645052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis].
    Hendriksen O; Petersen CL
    Ugeskr Laeger; 1995 Jul; 157(29):4138-9. PubMed ID: 7652995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolic events in 93 elderly Chinese patients with atrial fibrillation.
    Cao X; Wang S; Jiang L; Liu L; Huang H; Lu Z
    Chin Med J (Engl); 2000 Apr; 113(4):320-3. PubMed ID: 11775227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
    Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
    Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation and embolic complications.
    Maru M
    East Afr Med J; 1997 Jan; 74(1):3-5. PubMed ID: 9145567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial.
    Pérez-Gómez F; Salvador A; Zumalde J; Iriarte JA; Berjón J; Alegría E; Almería C; Bover R; Herrera D; Fernández C
    Eur Heart J; 2006 Apr; 27(8):960-7. PubMed ID: 16330464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of coumadin and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.
    Poungvarin N; Opartkiattikul N; Chaithiraphan S; Viriyavejakul A
    J Med Assoc Thai; 1994 Jan; 77(1):1-6. PubMed ID: 7798824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: the necessity of the maze procedure.
    Nakajima H; Kobayashi J; Bando K; Yasumura Y; Nakatani S; Kimura K; Niwaya K; Tagusari O; Kitamura S
    Ann Thorac Surg; 2004 Sep; 78(3):800-5; discussion 805-6. PubMed ID: 15336994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient, subclinical atrial fibrillation and risk of systemic embolism in patients with rheumatic mitral stenosis in sinus rhythm.
    Karthikeyan G; Ananthakrishnan R; Devasenapathy N; Narang R; Yadav R; Seth S; Singh S; Goswami KC; Bahl VK
    Am J Cardiol; 2014 Sep; 114(6):869-74. PubMed ID: 25086468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A longitudinal study on left atrial thrombosis in patients with non-rheumatic atrial fibrillation treated with anticoagulants].
    Scardi S; Mazzone C; Pandullo C; Goldstein D; Perkan A
    G Ital Cardiol; 1997 Oct; 27(10):1036-43. PubMed ID: 9359051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitra heart valve: results of a multicenter clinical study.
    Sankarkumar R; Bhuvaneshwar GS; Magotra R; Muralidharan S; Rajan RS; Saha D; Subba Rao KS; Valiathan MS; Radhakrishna S; Ramani AV
    J Heart Valve Dis; 2001 Sep; 10(5):619-27. PubMed ID: 11603602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
    Scardi S; Mazzone C; Pandullo C; Goldstein D; Di Lenarda A; Chersevani D
    G Ital Cardiol; 1999 Jun; 29(6):637-46. PubMed ID: 10396667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.